This company seems to have been delisted
Reason: Filed for chapter 7 bankruptcy
Last recorded trade on: December 27, 2023
Source: https://www.genomeweb.com/business-news/biocept-files-chapter-7-bankruptcy
Reason: Filed for chapter 7 bankruptcy
Last recorded trade on: December 27, 2023
Source: https://www.genomeweb.com/business-news/biocept-files-chapter-7-bankruptcy
Biocept
BIOC
£0.34
Share price
0.00%
Change (1 day)
-95.77%
Change (1 year)
Categories
Revenue for Biocept (BIOC)
Revenue in 2023 (TTM): -£2.49 Million
According to Biocept
's latest financial reports the company's current revenue (TTM 
) is -£2.7 Million. In 2022 the company made a revenue of £21.37 Million a decrease over the revenue in the year 2021 that were of £45.37 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Biocept from 2013 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | -£2.49 Million | -111.65% |
| 2022 | £21.37 M | -52.9% |
| 2021 | £45.37 M | 125.22% |
| 2020 | £20.14 M | 377.86% |
| 2019 | £4.21 M | 64.65% |
| 2018 | £2.56 M | -31.72% |
| 2017 | £3.75 M | 43.58% |
| 2016 | £2.61 M | 534.67% |
| 2015 | £0.41 M | 380.28% |
| 2014 | £0.08 M | 5.29% |
| 2013 | £0.08 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | £2.16 B | -80,392.99% | 🇺🇸 USA |
 | £0.65 B | -24,477.18% | 🇺🇸 USA |
 | £0.34 B | -13,073.34% | 🇺🇸 USA |